2 results
Approved WMOCompleted
To study the potential of baclofen as an anti-craving/relapse agent in GHB dependent patients.
Approved WMOCompleted
Primary Objective* To compare the effect of a 30-week course of mavacamten with placebo on clinical response comprising of exercise capacity and clinical symptoms in participants with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)…